6533b85ffe1ef96bd12c12d8
RESEARCH PRODUCT
Health-Relevant Phenotypes in the Offspring of Mice Given CAR Activators Prior to Pregnancy
Ute Gödtel-armbrustJan BaumgartTanja GrosserElke ButtLeonid EshkindLeszek WojnowskiMarianne MathäsChristof NiehrsKarin DietrichPiyush MoreFederico MariniLea ReuterMichael U. Musheevsubject
0301 basic medicinemedicine.medical_specialtyPyridinesOffspringDevelopmental toxicityReceptors Cytoplasmic and NuclearPharmaceutical ScienceAdipose tissueBiologyMice03 medical and health sciencesPregnancyInternal medicineConstitutive androstane receptormedicineAnimalsReceptorConstitutive Androstane ReceptorPharmacologyPregnancymedicine.diseaseEmbryo transferMice Inbred C57BLPhenotype030104 developmental biologyEndocrinologyAdipose TissueLiverNuclear receptorFemaledescription
Hepatic induction in response to drugs and environmental chemicals affects drug therapies and energy metabolism. We investigated whether the induction is transmitted to the offspring. We injected 3-day- and 6-week-old F0 female mice with TCPOBOP, an activator of the nuclear receptor constitutive androstane receptor (CAR, NR1I3), and mated them 1-6 weeks afterward. We detected in the offspring long-lasting alterations of CAR-mediated drug disposition, energy metabolism, and lipid profile. The transmission to the first filial generation (F1) was mediated by TCPOBOP transfer from the F0 adipose tissue via milk, as revealed by embryo transfer, crossfostering experiments, and liquid chromatography-mass spectrometry analyses. The important environmental pollutant PCB153 activated CAR in the F1 generation in a manner similar to TCPOBOP. Our findings indicate that chemicals accumulating and persisting in adipose tissue may exert liver-mediated, health-relevant effects on F1 offspring simply via physical transmission in milk. Such effects may occur even if treatment has been terminated far ahead of conception. This should be considered in assessing developmental toxicity and in the long-term follow-up of offspring of mothers exposed to both approved and investigational drugs, and to chemicals with known or suspected accumulation in adipose tissue.
year | journal | country | edition | language |
---|---|---|---|---|
2018-06-06 | Drug Metabolism and Disposition |